BATS BZX Real-Time Price
As of 10:46am ET
| -0.08 / -1.09%|
The 4 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +58.62% increase from the last price of 7.25.
The current consensus among 4 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.